STOCK TITAN

Hexo Corp Stock Price, News & Analysis

HEXO NYSE

Welcome to our dedicated page for Hexo news (Ticker: HEXO), a resource for investors and traders seeking the latest updates and insights on Hexo stock.

HEXO Corp (HEXO) is a Health Canada-licensed leader in medical marijuana production, recognized for advanced cultivation methods and pharmaceutical-grade quality standards. This news hub provides investors and industry observers with essential updates on corporate milestones, regulatory compliance, and market developments.

Access timely reports on earnings announcements, facility expansions, and strategic partnerships that shape HEXO's position in the cannabis sector. Track innovations in product development and cultivation technologies through verified press releases and objective analysis.

Key coverage areas span financial results, regulatory updates, production capacity changes, and research initiatives. All content undergoes rigorous verification to ensure alignment with Health Canada's ACMPR framework and financial reporting standards.

Bookmark this page for direct access to HEXO's official communications, including material change reports and partnership announcements. Combine these updates with our historical data repository for comprehensive analysis of the company's evolving market strategy.

Rhea-AI Summary

HEXO Corp has signed Purchase and Sale Agreements for its first US production facility in Northern Colorado, spanning approximately 50,000 sq. ft. This facility will enhance HEXO's ability to supply its Powered by HEXO® technology to US consumers and partners, including a joint venture with Molson Coors for CBD-infused beverages. The site is designed for diverse cannabinoid production, complying with all regulations. The transaction is set to close in Q4 2021, pending due diligence and standard conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

HEXO Corp. announced a partnership with REQ, a leading digital marketing firm, to boost its expansion in the U.S. market. REQ will serve as HEXO's Agency of Record, assisting in the growth of Truss CBD USA and supporting potential partnerships with non-beverage CPG companies. The collaboration aims to enhance HEXO's brand presence and accelerate its market opportunities. HEXO's CEO highlighted the potential for growth through this partnership, tapping into REQ's expertise in brand management.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
partnership
-
Rhea-AI Summary

HEXO Corp has launched an at-the-market equity program allowing the issuance of up to C$150,000,000 in common shares. These shares will be sold at market prices through the TSX, NYSE, and other exchanges. The program, effective until June 7, 2023, will support general corporate purposes, including U.S. expansion and capital expenditures. The sales will be managed through a distribution agreement with A.G.P./Alliance Global Partners and BMO Capital Markets. The company aims to use proceeds for acquisitions, working capital, and debt repayment related to Zenabis.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

OTTAWA, May 7, 2021 – HEXO Corp (TSX: HEXO; NYSE: HEXO) announced that CEO Sebastien St-Louis and CFO Trent MacDonald will present at Canaccord Genuity’s 5th Annual Global Cannabis Conference on May 11, 2021, at 4:00 p.m. ET. The Company will also hold investor meetings throughout the day. A live webcast of the presentation will be available on the Company’s website. HEXO is a leading cannabis company that distributes products in the Canadian adult-use and medical markets under various brands. For details, visit hexocorp.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Summary

HEXO Corp has successfully repaid its entire credit facility amounting to approximately $28.9 million as of April 30, 2021. This repayment was made under a credit agreement with Canadian Imperial Bank of Commerce and Bank of Montreal. CEO Sebastien St-Louis stated that this move enhances HEXO's financial flexibility as the company pursues its US expansion plans and aims to be a leading player in Canada’s recreational cannabis market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

HEXO Corp (TSX: HEXO; NYSE: HEXO) announced participation in the Alliance Global Partners 2021 Spring Consumer Cannabis Conference on May 4, 2021. CEO Sebastien St-Louis and CFO Trent MacDonald will represent the Company.

St-Louis will take part in a panel discussing the evolving competitive environment in Canada at 9:00 a.m. ET. Interested individuals can register for a live webcast on the Company’s events page. HEXO is a leading cannabis company known for its innovative products in the Canadian adult-use and medical markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
Rhea-AI Summary

HEXO Corp announced that its Masson-Angers cultivation campus has received the Control Union Medical Cannabis Standard GACP certification, establishing it as a leader in medical cannabis cultivation. This certification enhances HEXO's commitment to quality and compliance with World Health Organization guidelines. CEO Sebastien St-Louis emphasized its importance in capturing market share both in Canada and globally.

The CUMCS-GACP certification signifies quality in cannabis propagation, cultivation, and post-harvest processes, promising high standards for partners in the cannabis industry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

HEXO Corp has filed a new preliminary short form base shelf prospectus and a corresponding shelf registration statement with Canadian and U.S. securities regulators. This filing aims to provide HEXO flexibility for strategic initiatives in the U.S. and Canada, as stated by CEO Sebastien St-Louis. The prospectus allows HEXO to offer up to C$1.2 billion in securities over 25 months, which could fund expansion, acquisitions, and general corporate purposes. The filings can be accessed via SEDAR and EDGAR.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

HEXO Corp (TSX: HEXO; NYSE: HEXO) has launched a new brand, Bake Sale, aimed at providing affordable cannabis products. The brand offers some of the lowest prices per gram in Canada, with prices up to 20% lower than competitors. Bake Sale is designed for value-conscious consumers and those experimenting with cannabis cooking, featuring products like All Purpose Flower Sativa and Indica in 28 g formats. Initial feedback from provincial boards has been positive, potentially boosting HEXO's market share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

HEXO Corp (TSX: HEXO; NYSE: HEXO) announced that CEO Sebastien St-Louis and CFO Trent MacDonald will engage in a live Q&A at the Wolfe Research Consumer Access Day on March 26, 2021, at 9:15 a.m. ET. The event will be led by Greg Badishkanian and Spencer Hanus. HEXO is a leading cannabis company providing innovative products for the global market, serving both adult-use and medical sectors under various brands. For more details, visit hexocorp.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences

FAQ

What is the market cap of Hexo (HEXO)?

The market cap of Hexo (HEXO) is approximately 31.2M.
Hexo Corp

NYSE:HEXO

HEXO Rankings

HEXO Stock Data

31.24M
42.86M
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Canada
Ottawa